Supply Chain

Can technology really build trust in pharmaceutical supply chains?

Quris’s system can help predict clinical safety, AI firm notes

Magellan Rx Management and Zipline have collaborated on a pilot project to deliver prescription medications directly to patients’ homes via autonomous aircraft. Magellan Rx CEO Mostafa Kamal discusses how this innovative delivery method aims to reduce barriers to care.

Collaboration, the companies note, is expected to further engage patients

Action offers the fulfillment of a critical part of the Drug Supply Chain Security Act (DSCSA)

A sit-down with members of the Deloitte team, who discuss the findings of the company’s yearly research and development report

USP study reveals urgency to make changes, with additional concerns coming to light amid times of crisis

Logistics provider’s investment will develop distribution area by an additional 27%

Acquisition expands Medable’s global engineering talent and gives company a third location in Europe

CDMO will use its BFS knowledge to support production out of its Kaysersberg, France plant

Following a November FDA public meeting, HDA reiterates the objections it had to guidance FDA issued in mid-2021 under the Drug Supply Chain Security Act (DSCSA)

The benefits of establishing an in-depth go-to-market commercialization strategy for a new CGT in the beginning of clinical trials

Merger with Phlexglobal expands provider’s technological capabilities

Expansion of the collaboration features a reduction in carbon dioxide emissions

Integrated system intends to accelerate enrollment by strengthening relationship between hub patient services and providers

Anticipated yearly production is 2 million units

In a civil action, Gilead alleges an extensive, transnational counterfeiting ring of HIV and other drugs

Partnership looks to ensure that chargebacks for suppliers are as accurate as possible

Companies to focus on market access strategies

With the delivery of Covid-19 booster shots in full swing, how does this effort compare to the initial vaccine distribution—and is the pharma supply chain adapting accordingly?

Acquisition of 86,000 square-foot plant has capability of manufacturing 1.8 billion capsules annually

Deal helps expands software company’s labeling capabilities in clinical trial, med device and pharma spaces

Protagen, BioAnalytix and GeneWerk merger set to target biopharma, C&GT sectors

Tufts analysis uncovers various benefits to conducting decentralized clinical trials—including financial benefits